Depression and Anxiety SymptomNCT07391540
ICBT for Psychological Symptoms Related to Economy
A study testing Internet-based cognitive behavioral therapy in people with Depression and Anxiety Symptom, run by Linkoeping University at 1 site in Sweden.
Trial summary
This study aims to investigate the effects of guided internet-based cogitive behavioral therapy (ICBT) on psychological symptoms related to economy. In this pilot study, the investigators investigate participants' psychological symptoms before and after, and one and two years after, they have received eight weeks of… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Depression and Anxiety Symptom
- What is being tested?
- Internet-based cognitive behavioral therapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteSweden
- Study dates
- 14 Jan 2026to 31 May 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Experience mild to moderate psychological symptoms or problems related to economy
- 18 years or older
- Ability to speak, read and write in Swedish
- Have access to the internet and a smartphone, computer or other device
Who cannot join
- Severe psychiatric or somatic illness that makes participation harder or impossible
- Ongoing addiction
- Acute suicidality
- Other ongoing psychological treatment
- Recent (within the latest month) changes in the dose of psychotropic medication or planned change of dose during the treatment weeks
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Sweden1 site, 1 recruiting
- Recruiting
Department of Behavioral Sciences and Learning
Linköping, Östergötland County, 58183
Gerhard Andersson, PhD, +46-13285840, gerhard.andersson@liu.se
About this study
Official title: Ekorostudien - Internet-based Cognitive Behavioral Therapy for Psychological Symptoms Related to Economy
This study aims to investigate the effects of guided internet-based cogitive behavioral therapy (ICBT) on psychological symptoms related to economy. In this pilot study, the investigators investigate participants' psychological symptoms before and after, and one and two years after, they have received eight weeks of therapist guided ICBT.
Read the detailed description
The treatment the investigators investigate has been developed from earlier treatments used in studies that have shown to be effective for symptoms of depression, anxiety, and stress, among others. Participants will in this pilot study undergo ICBT with weekly guidance by a therapist and in a within-group design, the investigators will compare their self-reported psychological symptoms from before and after the treatment. A one- and two-year follow-up are also planned.
- Conditions
- Depression and Anxiety Symptom
- Being tested
- Internet-based cognitive behavioral therapy
- Keywords
- Internet-based cognitive behavioral therapy (ICBT), Psychological treatment, Economy, Depression
- Medical subject headings
- Depression, Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Internet-based cognitive behavioral therapyBehavioural
Also called ICBT
The treatment consists of eight treatment modules that the participants receive, one module each week in eight weeks. The modules consists of texts, pictures and interactive exercises. The participants also get weekly guidance by a therapist and they can contact their therapist during the week if needed.
| Study group | Role | What they receive |
|---|---|---|
| Treatment group | Experimental | All included participants will undergo eight weeks of ICBT with weekly support by a therapist. Receives: Behavioral: Internet-based cognitive behavioral therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
InCharge Financial Distress/Financial Well-Being Scale
The InCharge Financial Distress/Financial Well-Being Scale is a measure aiming to measure distress related to the individual's economic situation. It contains of eight questions where the respondent gets to answer on a scale from 1 to 10. This score is then divided by eight (number of questions) and total score is between 1 and 8. A higher score indicates better financial well-being.
Measured: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
Mongomery-Asberg Depression Rating Scale - Självrapportering
The Mongomery-Asberg Depression Rating Scale - Självrapportering is a self-report questionnaire that aim to measure symptoms of depression. It consists of 9 items and the repondent answers on a scale from 0 to 6. Scoring range is between 0-54. A higher score indicates more (severe) depression symptoms.
Measured: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
Generalized Anxiety Scale-7 item scale
The Generalized Anxiety Scale-7 item scale aim to measure anxiety symptoms and worry. When summing the points of the seven first questions, the scores are interpreted as mild, moderate and severe anxiety symptoms at 5-10, 11-15 and above 15 respectively. Thus, a higher score indicates higher levels of anxiety and worry. Total score range is between 0 and 21.
Measured: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
Secondary outcomes (5)
Perceived Stress Scale-14
The Perceived Stress Scale-14 is a questionnaire that aims to measure symptoms of stress. I contains 14 items that are scored on a range betewwn 0 (never) to 4 (very often). The total score range is between 0-56 and a higher score reflects higher levels of perceived stress.
Measured: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
Insomnia Severity Index
The Insomnia Severity Index is a measure of insomnia severity and symptoms of disordered sleep. Norm score ranges include low likelihood of sleep problems (0 to 7 points), some sleep problems (8 to 14 points), moderate sleep problems (15 to 21 points), and severe sleep problems (22 to 28 points). Thus, a higher score indicates more symptoms of insomnia. The score range is between 0 and 28.
Measured: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
Brunnsviken Brief Quality of Life Scale
The Brunnsviken Brief Quality of Life Scale is a measure of quality of life with a total score ranging from 0 to 96, with a higher score indicating a higher quality of life. The scores of each of the six primary questions regarding perceived quality of life within an area of life are multiplied by the score of an item measuring the perceived importance of the area in question.
Measured: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
Goldberg's (1999) International Personality Item Pool representation of Costa McCrae's (1992) Neuroticism-Extraversion-Openness Personality Inventory - Revised Domains
The Goldberg's (1999) International Personality Item Pool representation of Costa McCrae's (1992) Neuroticism-Extraversion-Openness Personality Inventory - Revised Domains is a measure of neuroticism. It consists of 10 items, scored from 0 (Very inaccurate) to 4 (Very accurate). A higher score indicates neurotic traits to a greater extent. The total score ranges from 0 to 40.
Measured: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
Rosenberg's Self-esteem Scale
The Rosenberg's Self-esteem Scale is a measure of self-esteem, consisting of ten items where five of them are positively and five of them are negatively worded. Sum scores range between 0 and 30. A higher score indicates higher self-esteem.
Measured: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Feb 2026
- Study start14 Jan 2026
- Primary completion31 May 2028 (estimated)
- Study completion31 May 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Depression and Anxiety SymptomStudies of the same condition, open and under way.
- More trials run by Linkoeping UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- All included participants will undergo the treatment simultaneously.
- Masking
- None (open label)
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Linkoeping University
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Gerhard Andersson, Linkoeping University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07391540
- Sponsor's protocol ID
- Ekorostudien
- Status last verified
- Feb 2026
- First submitted
- 13 Jan 2026
- Last updated
- 6 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Ekorostudien - Internet-based Cognitive Behavioral Therapy for Psychological Symptoms Related to Economy
- ClinicalTrials.gov ID
- NCT07391540
- Acronym / sponsor ID
- Ekorostudien
- Conditions
- Depression and Anxiety Symptom
- Keywords
- Internet-based cognitive behavioral therapy (ICBT), Psychological treatment, Economy, Depression
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Linkoeping UniversityOther government
- Study start
- 14 Jan 2026 (actual)
- Primary completion
- 31 May 2028 (estimated)
- Study completion
- 31 May 2028 (estimated)
- First posted
- 6 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to investigate the effects of guided internet-based cogitive behavioral therapy (ICBT) on psychological symptoms related to economy. In this pilot study, the investigators investigate participants' psychological symptoms before and after, and one and two years after, they have received eight weeks of therapist guided ICBT.
Detailed description
The treatment the investigators investigate has been developed from earlier treatments used in studies that have shown to be effective for symptoms of depression, anxiety, and stress, among others. Participants will in this pilot study undergo ICBT with weekly guidance by a therapist and in a within-group design, the investigators will compare their self-reported psychological symptoms from before and after the treatment. A one- and two-year follow-up are also planned.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- All included participants will undergo the treatment simultaneously.
| Arm | Type | Receives |
|---|---|---|
| Treatment group | Experimental | Behavioral: Internet-based cognitive behavioral therapyAll included participants will undergo eight weeks of ICBT with weekly support by a therapist. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Experience mild to moderate psychological symptoms or problems related to economy
- 18 years or older
- Ability to speak, read and write in Swedish
- Have access to the internet and a smartphone, computer or other device
Key exclusion criteria (5 listed)
- Severe psychiatric or somatic illness that makes participation harder or impossible
- Ongoing addiction
- Acute suicidality
- Other ongoing psychological treatment
- Recent (within the latest month) changes in the dose of psychotropic medication or planned change of dose during the treatment weeks
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Internet-based cognitive behavioral therapyAlso: ICBTThe treatment consists of eight treatment modules that the participants receive, one module each week in eight weeks. The modules consists of texts, pictures and interactive exercises. The participants also get weekly guidance by a therapist and they can contact their therapist during the week if needed. | Behavioural | Treatment group |
Primary outcome
InCharge Financial Distress/Financial Well-Being Scale
Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
The InCharge Financial Distress/Financial Well-Being Scale is a measure aiming to measure distress related to the individual's economic situation. It contains of eight questions where the respondent gets to answer on a scale from 1 to 10. This score is then divided by eight (number of questions) and total score is between 1 and 8. A higher score indicates better financial well-being.
Mongomery-Asberg Depression Rating Scale - Självrapportering
Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
The Mongomery-Asberg Depression Rating Scale - Självrapportering is a self-report questionnaire that aim to measure symptoms of depression. It consists of 9 items and the repondent answers on a scale from 0 to 6. Scoring range is between 0-54. A higher score indicates more (severe) depression symptoms.
Generalized Anxiety Scale-7 item scale
Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
The Generalized Anxiety Scale-7 item scale aim to measure anxiety symptoms and worry. When summing the points of the seven first questions, the scores are interpreted as mild, moderate and severe anxiety symptoms at 5-10, 11-15 and above 15 respectively. Thus, a higher score indicates higher levels of anxiety and worry. Total score range is between 0 and 21.
5 secondary outcomes
Perceived Stress Scale-14
Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
Insomnia Severity Index
Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
Brunnsviken Brief Quality of Life Scale
Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
Goldberg's (1999) International Personality Item Pool representation of Costa McCrae's (1992) Neuroticism-Extraversion-Openness Personality Inventory - Revised Domains
Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
Rosenberg's Self-esteem Scale
Time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Feb 2026.
Related trials for Depression and Anxiety Symptom
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Recruiting
Cultural Adaptation of an Online Parenting Intervention to Reduce the Risk of Depression and Anxiety in Adolescents
Risk of Depression and Anxiety
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Internet-based cognitive behavioral therapy in people with Depression and Anxiety Symptom, run by Linkoeping University at 1 site in Sweden.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 6 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Gerhard Andersson, PhD (+46-13285840, gerhard.andersson@liu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
InCharge Financial Distress/Financial Well-Being Scale (time frame: Participants will complete this questionnaire at baseline, immediately after treatment, one year after treatment, and two years after treatment completion.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2026.